Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 5/2013

01-05-2013 | Systematic Review

Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review

Authors: Cristian Gonzalez-Gonzalez, Elena Lopez-Gonzalez, Maria T. Herdeiro, Adolfo Figueiras

Published in: Drug Safety | Issue 5/2013

Login to get access

Abstract

Background

Underreporting is the major limitation of a voluntary adverse drug reaction (ADR) reporting system. Many studies have assessed the effectiveness of different interventions designed to reduce underreporting.

Objective

We aimed to conduct a critical review of papers that assessed the effectiveness of different strategies to increase ADR reporting, regardless of the health professionals or patients included.

Data Sources

Scientific papers were selected after a search of the MEDLINE-PubMed and EMBASE scientific databases up to 7 December 2010.

Study Selection

We included papers in English, French or Spanish that analysed an intervention aimed at increasing the number of reported ADRs, and quantify the results of the intervention in terms of number of reports.

Data Extraction

The abstracts retrieved in both computerized searches were reviewed independently by two of the authors. Initially selected papers were thoroughly read to evaluate if they met inclusion and exclusion criteria. Data in finally selected papers were independently extracted by both authors and set in pre-designed tables. A third author took the final decision in case of disagreement. For each study, we analysed study design, type of intervention, assessment period, and results of the intervention.

Results

Of the 4,221 papers located that fulfilled the search criteria, 43 met the selection criteria. With the exception of one study, the interventions assessed were deemed to be effective. The vast majority of papers displayed methodological and formal limitations that lowered the grade of evidence. Multiple interventions seem to have had more impact than did single interventions. There were very few cases in which interventions were designed on the basis of inappropriate attitudes and mistaken beliefs about ADRs.

Conclusions

In general, there is a need for studies of better methodological quality in this topic, so that more evidence of the effectiveness of the respective strategies can be collected for the purpose of improving ADR reporting by health professionals. It is probable that multiple interventions cause greater increases in the ADR reporting rates than single.
Literature
1.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.PubMedCrossRef
2.
Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7:8.PubMedCrossRef
3.
Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385–96.PubMedCrossRef
4.
Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19–31.PubMedCrossRef
5.
Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clin Epidemiol. 2009;1:75–92.PubMed
6.
Van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13:457–64.PubMedCrossRef
7.
8.
9.
Miwa LJ, Randall RJ. Adverse drug reaction program using pharmacist and nurse monitors. Hosp Formul. 1986;21:1140–3, 1146.
10.
Michel DJ, Knodel LC. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital. Am J Hosp Pharm. 1986;43:2202–5.PubMed
11.
Cantú TG, Tyler LS. Development of a hospital-based adverse drug reaction reporting program. Hosp Formul. 1988;23:658–61.PubMed
12.
Kimelblatt BJ, Young SH, Heywood PM, Mandala AR, Gendelman S, Mehl B. Improved reporting of adverse drug reactions. Am J Hosp Pharm. 1988;45:1086–9.PubMed
13.
Winstanley PA, Irvin LE, Smith JC, Orme LE. Breckenridge. Adverse drug reactions: a hospital pharmacy-based reporting scheme. Br J Clin Pharmacol. 1989;28:113–6.PubMedCrossRef
14.
Vorce-West TE, Barstow L, Butcher B. System for voluntary reporting of adverse drug reactions in a university hospital. Am J Hosp Pharm. 1989;46:2300–3.PubMed
15.
Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ Jr, Green M, Andrews LG, Faich GA. Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA. 1990;263:1785–8.PubMedCrossRef
16.
Feely J, Moriarty S, O’Connor P. Stimulating reporting of adverse drug reactions by using a fee. BMJ. 1990;300(6716):22–3.PubMedCrossRef
17.
Gilroy GW, Scollins MJ, Gay CA, Harry DJ, Giannuzzi DF. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm. 1990;47:1327–33.PubMed
18.
Chatas CA, Vinson BE. Program for improving adverse drug reaction reporting. Am J Hosp Pharm. 1990;47:155–7.PubMed
19.
Prosser TR, Kamysz PL. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm. 1990;47:1334–9.PubMed
20.
Nazario M, Feliú JF, Rivera GC. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience. Hosp Pharm. 1994;29:244–6, 249–50.
21.
Yee WP, Norton LL, Catania HF. Developing a comprehensive medication reaction reporting system. Hosp Pharm. 1995;30:384–5, 389–91, 394–6.
22.
Szymusiak-Mutnick BA, Ross MB. Increased adverse drug reaction reporting through wall-mounted ADR reporting cards. Formulary. 1995;30:471–3.PubMed
23.
Saltiel E, Johnson E, Shane R. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital. Hosp Formul. 1995;30:226–8, 231–2.
24.
Orsini MJ, Orsini PA, Thorn DB, Gallina JN. An ADR surveillance program: increasing quality, number of incidence reports. Formulary. 1995;30:454–61.PubMed
25.
Sivaram CA, Johnson S, Tirmizi SN, Robertson V, Garcia D, Sorrells E. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv. 1996;22:259–63.PubMed
26.
Welsh CH, Pedot R, Anderson RJ. Use of morning report to enhance adverse event detection. J Gen Intern Med. 1996;11:454–60.PubMedCrossRef
27.
McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997;44:98–100.PubMedCrossRef
28.
Ball D, Tisócki T. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare: a pilot study. Cent Afr J Med. 1998;44:190–5.PubMed
29.
Schlienger RG, Luscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21:110–5.PubMedCrossRef
30.
Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child. 2001;84:337–9.PubMedCrossRef
31.
Bäckström M, Mjörndal T, Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf. 2002;11:647–50.PubMedCrossRef
32.
Ryan M, Gora-Harper ML, Caldwell F. Experience with an adverse drug reaction reporting program in a neurology specialty clinic. Ann Pharmacother. 2002;36:231–5.PubMedCrossRef
33.
Aspinall MB, Whittle J, Aspinall SL, Maher RL Jr, Good CB. Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital. Am J Health Syst Pharm. 2002;59:841–5.PubMed
34.
Rosebraugh CJ, Tsong Y, Zhou F, Chen M, Mackey AC, Flowers C, et al. Improving the quality of adverse drug reaction reporting by 4th-year medical students. Pharmacoepidemiol Drug Saf. 2003;12:97–101.PubMedCrossRef
35.
Castel JM, Figueras A, Pedrós C, Laporte JR, Capellà D. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf. 2003;26:1049–55.PubMedCrossRef
36.
Perkerson KA, Quercia RA, Goldman M, Goddu G, Coleman CI. Can a multidisciplinary initiative to increase adverse drug reaction reporting work? Conn Med. 2004;68:281–4.PubMed
37.
Bracchi RC, Houghton J, Woods FJ, Thomas S, Smail SA, Routledge PA. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. Br J Clin Pharmacol. 2005;60:221–3.PubMedCrossRef
38.
Bäckström M, Mjörndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions: a way of dealing with an old problem? Eur J Clin Pharmacol. 2006;62:381–5.PubMedCrossRef
39.
Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429–34.PubMedCrossRef
40.
Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296:1086–93.PubMedCrossRef
41.
Sullivan KM, Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am J Health Syst Pharm. 2008;65:1177–9.PubMedCrossRef
42.
Ortega A, Aguinagalde A, Lacasa C, Aquerreta I, Fernández-Benítez M, Fernández LM. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother. 2008;42:1491–6.PubMedCrossRef
43.
Herdeiro MT, Polónia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31:335–44.PubMedCrossRef
44.
Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, Matthes H. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009;9:274.PubMedCrossRef
45.
Johansson ML, Brunlöf G, Edward C, Wallerstedt SM. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports. Eur J Clin Pharmacol. 2009;65:511–4.PubMedCrossRef
46.
Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009;32:77–83.PubMedCrossRef
47.
Anton C, Cox AR, Ferner RE. Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK. Drug Saf. 2009;32:1135–40.PubMedCrossRef
48.
Sevene E, Mariano A, Mehta U, Machai M, Dodoo A, Vilardell D, Patel S, et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008;31:867–76.PubMedCrossRef
49.
Gross R, Strom BL. Toward improved adverse event/suspected adverse drug reaction reporting. Pharmacoepidemiol Drug Saf. 2003;12:89–91.PubMedCrossRef
50.
Improving ADR reporting. Lancet. 2002;360:1435.
51.
McCloskey BA. Improving adverse drug reaction reporting in the community setting. Med Interface. 1996;9:85–7.PubMed
52.
Schiff GD. Using a computerized discharge summary data base check box for adverse drug reaction monitoring. QRB Qual Rev Bull. 1990;16:149–55.PubMed
53.
Damiani DR, Swanson DP. Pharmacist-managed monitoring of adverse reactions to contrast media. Am J Hosp Pharm. 1994;51:358–63.PubMed
54.
55.
Gony M, Badie K, Sommet A, Jacquot J, Baudrin D, Gauthier P, et al. Improving adverse drug reaction reporting in hospitals. Drug Saf. 2010;33:409–16.PubMedCrossRef
56.
Valente SM. Improving professional practice through certification. J Nurses Staff Dev. 2010;26:215–9.PubMedCrossRef
57.
Kabanywanyi AM, Mulure N, Migoha C, Malila A, Lengeler C, Schlienger R, Genton B. Experience of safety monitoring in the context of a prospective observational study of artemether–lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting. Malaria J. 2010;9:205.CrossRef
58.
Cereza G, Agustí A, Pedrós C, Vallano A, Aguilera C, Danés I, et al. Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. Eur J Clin Pharmacol. 2010;66:937–45.PubMedCrossRef
59.
Smith Rogers A. Strategies to promote physician reporting of adverse drug events based on the experience of an FDA-sponsored project in Maryland. J Clin Res Drug Dev. 1989;3(1):29–37.
60.
Rosenbaum SE, Thacher-Renshaw A, Green M, Waters WJ Jr. Interventions to increase physician participation in a voluntary reporting system: the Rhode Island adverse drug reaction reporting project. Clin Res Reg Aff. 1992;9(4):261–75.CrossRef
61.
Sharkey CC, Alessandro-Battaglia R, Matuszewski J, Peker S, Lovly RM. A seven-step approach to improving ADR-reporting rates at a Department of Veterans Affairs medical center. Pharm Ther. 1999;24(7):327–31.
62.
Colodny L, Spillane J. Toward increased reporting of adverse drug reactions. Hosp Pharm. 1999;34(10):1179–85.
63.
Vaz I, Herdeiro MT, Figueiras A, Polonia J. Strategies for increasing spontaneous adverse drug reaction reporting rates among Portuguese health professionals. 9th ISoP Annual Meeting. From Pharmacovigilance to Risk Management™; Reims; 2009 Oct 6–9. Drug Saf. 2009;32(10):878–9.
64.
Prakongsai N, Pongchaidecha M. Using collaborative program between pharmacists and nurses to improve spontaneous adverse drug reaction reporting system in Thailand. ISPOR; 4th Asia-Pacific Conference; Phuket. 2010 Sep 5–7. Value Health. 2010;13(7):A537.CrossRef
65.
Yen YH, Kuo LN, Hsu MH, Li YC, Cheng KJ. Evaluation of the electronic adverse drug event management system. J Exp Clin Med. 2010;2(6):287–91.CrossRef
66.
Gardner P, Watson LJ. Adverse drug reactions: a pharmacist-based monitoring system. Clin Pharmacol Ther. 1970;11:802–7.PubMed
67.
Kilarski DJ, Xiegler B, Coarse J, Buchanan C. Adverse drug reaction reporting system: developing a well-monitored program. Hosp Formul. 1986;21:949–52.PubMed
68.
Lee SB, Schepers GP, Goldberg KL. Electronic adverse-drug-reaction-reporting program. Am J Health Syst Pharm. 2004;61:1230, 1232–3.
69.
Wallerstedt SM, Brunlof G, Johansson ML, Tukukino C, Ny L. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor. Eur J Clin Pharmacol. 2007;63:505–8.PubMedCrossRef
70.
Jacinto MS, Kleinmann K. Hospital pharmacy program for reporting adverse drug reactions. Am J Hosp Pharm. 1983;40:444–5.PubMed
71.
Fincham J. A statewide program to stimulate reporting of adverse drug reactions. J Pharm Pract. 1989;2:239–44.CrossRef
72.
Griffin JP. Is better feedback a major stimulus to spontaneous adverse reaction monitoring? Lancet. 1984;2(8411):1098.PubMedCrossRef
73.
O’Connor P, Moriarty JM, Feely J. Adverse drug reactions: incentives to enhance reporting. Br J Clin Pharmacol. 1988;26:616.
74.
Poorolajal J, Cheraghi Z, Irani AD, Rezaeian S. Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. Epidemiol Health. 2011;33:e2011005.PubMed
75.
Moher D, Schulz KF, Altman D, CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987–91.PubMedCrossRef
76.
Figueiras A, Sastre I, Gestal-Otero JJ. Effectiveness of educational interventions on the improvement of drug prescription in primary care: a critical literature review. J Eval Clin Pract. 2001;7:223–41.PubMedCrossRef
77.
Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson N. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010;(3):CD005470.
78.
Bokhoven Van, Kok G, Van der Weijden T. Designing a quality improvement intervention: a systematic approach. Qual Saf Health Care. 2003;12:215–20.PubMedCrossRef
79.
Forsetlund L, Bjørndal A, Rashidian A, Jamtvedt G, O’Brien MA, Wolf F, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;(2):CD003030.
80.
Boaz A, Baeza J, Fraser A, European Implementation Score Collaborative Group. Effective implementation of research into practice: an overview of systematic reviews of the health literature. BMC Res Notes. 2011;4:212.PubMedCrossRef
Metadata
Title
Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review
Authors
Cristian Gonzalez-Gonzalez
Elena Lopez-Gonzalez
Maria T. Herdeiro
Adolfo Figueiras
Publication date
01-05-2013
Publisher
Springer International Publishing AG
Published in
Drug Safety / Issue 5/2013
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-013-0058-2

Other articles of this Issue 5/2013

Drug Safety 5/2013 Go to the issue

Review Article

Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)

Short Communication

Ischaemic Colitis in Rheumatoid Arthritis Patients Receiving Tumour Necrosis Factor-α Inhibitors: An Analysis of Reports to the US FDA Adverse Event Reporting System

Original Research Article

The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions

Original Research Article

Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

Original Research Article

Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso

Original Research Article

Effects of Maternal Epilepsy and Antiepileptic Drug Use during Pregnancy on Perinatal Health in Offspring: Nationwide, Retrospective Cohort Study in Finland